IFPMA News: Speeches

Speeches


Filter:	Author

Supachai Panitchpakdi

Director General, World Trade Organisation (WTO)

27 October 2004	KEYNOTE PRESENTATION BY THE WTO DIRECTOR-GENERAL IFPMA GENERAL ASSEMBLY, Barcelona, SPAIN

Sidney Taurel

Chairman, President, and Chief Executive Officer - Eli Lilly and Company

4 November 2003	Where Drugs Come From: The Facts of Life About Pharmaceutical Innovation Remarks to Hudson Institute Forum - National Press Club, Washington, D.C.

18 March 2003	The Campaign Against Innovation Remarks to American Enterprise Institute, Washington D.C.

Robert Essner

Chairman of the Board of Directors, PhRMA

29 March 2003	PhRMA 2003 Annual Meeting PhRMA 2003 Annual Meeting, Washington D.C.

Raymond V. Gilmartin

Chairman, President & CEO - Merck & Co., Inc.

17 June 2003	A Prescription for Change in U.S. Health Care National Press Club, Washington, D.C.

Fred Hassan

President & CEO of Pharmacia

29 March 2003	Remarks - PhRMA 2003 Annual Meeting Board of Directors - PhRMA 2003 Annual Meeting, Washington D.C.

Dr. Henry A. McKinnell

Chairman and CEO Pfizer Inc.

13 May 2004	Contribution of Research and Innovation to Improving Performance of Health Systems Address to OECD Health Ministers Round Table, Paris

Dr Harvey E. Bale Jr.

Director General, International Federation of Pharmaceutical Manufacturers Associations

President, Pharmaceutical Security Institute

20 January 2005	Statement by Director General of IFPMA - Agenda Item 4.9 "Antiretrovirals and Developing Countries" World Health Organisation 115th Executive Board, Geneva

21 January 2004	QUALITY AND SAFETY OF MEDICINES, INCLUDING OF BLOOD PRODUCTS WHO Executive Board, Geneva, Switzerland

20 May 2003	Submission of Intervention at the 56th World Health Assembly 56th World Health Assembly, Geneva, Switzerland

1 - 10 of 18